 |
| Global Intravenous Solutions Market Size |
Intravenous solutions or IV fluids are used for fluid replacement and correct
electrolyte imbalances through intravenous administration. IV solutions help
provide essential nutrients and fluids to dehydrated or malnourished patients.
The
Intravenous Solutions Market is estimated to be valued at US$ 577228 Mn in 2023 and is expected to exhibit a CAGR of 10% over the forecast period
2023 to 2030, as highlighted in a new report published by Coherent Market
Insights.
Market key trends:
One of the major trends fueling the growth of the intravenous solutions market
is the growing popularity of nutritional supplements and nutraceutical products
in IV formulations. Several companies are developing intravenous nutraceutical
solutions with enriched formulations containing vitamins, minerals, proteins,
amino acids, botanical extracts, and other nutrients meant for therapeutic
benefits beyond basic hydration. For example, IV vitamin therapy uses
intravenous administration of various vitamins and is gaining widespread
acceptance for its quick absorption and utilization by cells compared to oral
supplements. The growing demand for advanced IV solutions integrated with
healthcare nutrition is expected to drive the market during the forecast
period.
Segment Analysis
The global intravenous solutions market is segmented on the basis of type,
application, end use, and geography. By type, the market is classified into
total parenteral nutrition, peripheral parenteral nutrition, intravenous
solutions. The total parenteral nutrition segment dominated the market in 2022
due to rising incidence of malnutrition.
Key Takeaways
The Global
Intravenous Solutions Market Size is expected to witness high growth,
exhibiting CAGR of 10% over the
forecast period, due to increasing prevalence of chronic diseases.
Regional analysis
North America dominated the intravenous solutions market in 2022 due to
increasing adoption of parenteral nutrition in the region. The market in Asia
Pacific is expected to grow at the fastest pace during the forecast period
owing to rising healthcare spending and availability of low-cost solutions.
Key players
Key players operating in the intravenous solutions market are Baxter
International Inc., ICU Medical. Inc, B. Braun Melsungen Ag, Grifols, S.A.,
Fresenius Kabi USA, LLC, Vifor Pharma Management Ltd, JW Life Science, Amanta
Healthcare, Axa Parenterals Ltd, and Salius Pharma Private Limited, Pfizer,
Inc, Otsuka Pharmaceutical Co., Ltd, Ajinomoto Co., Inc., B. Braun Melsungen
AG, Soxa Formulations & Research Pvt.Ltd, Sichuan Kelun Pharmaceutical Co
Ltd.
Explore
More Information On This Topic @ https://www.pressreleasebulletin.com/intravenous-solutions-market-analysis/